Taro Pharmaceutical
TARO
#5309
Rank
$1.61 B
Marketcap
$42.97
Share price
0.00%
Change (1 day)
8.18%
Change (1 year)

EPS for Taro Pharmaceutical (TARO)

EPS in 2023 (TTM): $0.61

According to Taro Pharmaceutical's latest financial reports the company's current EPS (TTM) is $1.22. In 2021 the company made an earnings per share (EPS) of $0.04000 an increase over its 2020 EPS that were of -$7.91.

EPS history for Taro Pharmaceutical from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.61
2021$0.04000-100.51%
2020-$7.91-222.45%
2019$6.46-18.02%
2018$7.8853.01%
2017$5.15-55.95%
2016$11.69-13.41%
2015$13.5036.92%
2014$9.8637.71%
2013$7.1621.15%
2012$5.9144.15%
2011$4.10175.17%
2010$1.49-48.8%
2009$2.91
2005$0.03000-91.89%
2004$0.37-82.55%
2003$2.1235.9%
2002$1.5639.29%
2001$1.12140.86%
2000$0.4669.09%
1999$0.28139.13%
1998$0.1264.29%
1997$0.07000-36.36%
1996$0.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$6.68 447.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$5.25 330.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$0.76-37.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$0.99-18.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$2.88 135.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
$0.63-48.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel